Skincare Reviewed Jul 5, 2026

La Roche-Posay Effaclar Duo Acne Treatment

A premium "derm" benzoyl-peroxide treatment recalled for benzene in 2025.

Recall · 2025 · resolved

FDA benzoyl-peroxide benzene recall

One of six BPO products voluntarily recalled at retail in March 2025 (lot MYX46W) after FDA testing found elevated benzene. Resolved.

Source →

Our take

Why It’s on Our Radar

We don't recommend the recalled lot. A premium derm brand FDA-recalled for benzene — a cautionary listing showing the issue crosses price tiers.

What's inside

Ingredients & Safety

Benzoyl peroxide, which can degrade into benzene — the reason a specific lot was recalled.

Worth a closer look — 1 ingredient we flag:

Benzoyl Peroxide 5.5% — sometimes listed as BPO

An acne active that can chemically break down into benzene, a known carcinogen, especially when stored warm — the basis of the 2024–2025 FDA testing and recalls.

Ingredient List Reviewed

Safe Watch Caution
  • Benzoyl Peroxide 5.5%
  • Water also listed as Aqua, Purified Water
  • Glycerin also listed as Glycerine, Vegetable Glycerin
  • Silica also listed as Silica, E551
  • Dimethicone
  • Niacinamide

Formula scope: the disclosed ingredient list captured for this review. Formulas can differ by product, scent, country, and date; compare the current package with this list before deciding.

Want another top-tier option? Three Ships in Skincare currently meets our top criteria. Review its formula scope and cited records before deciding.

Who owns it

Ownership & Independence

La Roche-Posay is owned by L'Oréal.

Where to buy

Key Products

As an Amazon Associate, we earn from qualifying purchases. Commissions never influence scores.

Check the exact formula, size, seller, and availability on Amazon. Search links show results that may include other brands. Links open in a new tab.